BrdU (Bromodeoxyuridine) (BRD469 + BRD494 + BRD.3), 0.2mg/mL
Bromodeoxyuridine (BrdU) is a synthetic nucleoside thymidine analog. It is commonly used to detect proliferation in cells. In cells cultured in the presence of BrdU, BrdU will incorporate into newly synthesized DNA during S-phase. Antibodies specific for BrdU can then be used to detect replicated DNA. This antibody is available purified, with BSA (0.2 mg/mL) or purified, BSA-free (1 mg/mL) .
Product Specifications
CAS Number
9007-83-4
Synonyms
Bromodeoxyuridine; 5-bromo-2-deoxyuridine
UNSPSC
41116161
UNSPSC Description
Primary and secondary antibodies for multiple methodology immunostaining detection application
Gene Name
Not Applicable
UniProt
Not Applicable
Swiss Prot
Not Applicable
Host
Mouse
Species Reactivity
Pan species
Reactivity
BrdU
Immunogen
Bromodeoxyuridine (BrdU) conjugated to BSA or KLH
Target Antigen
BrdU
Clonality
Monoclonal
Clone
BRD469 BRD494 BRD.3
Type
Primary
Source
Animal
Origin
Animal
Applications
IHC, FFPE (verified)
Field of Research
Cancer, Cell cycle
Positive Control
Cells grown in presence of BrdU or tissues from experimental animals injected with BrdU
Stability
2 years
Concentration
0.2 mg/mL
Buffer
PBS, 0.05% BSA, 0.05% azide
Molecular Weight
Depends on the target
Shipping Conditions
RT (ND)
Storage Conditions
Stable at room temperature or 37°C (98°F) for 7 days.
Shelf Life
Guaranteed for at least 24 months from date of receipt when stored as recommended
Fragment
IgG1
Species
Mus musculus (mouse), BSA from bovine serum (Bos taurus) or recombinant BSA produced in Chinese hamster ovary cells.
Classification
PBS, 0.05% BSA, 0.05% sodium azide (CAS 26628-22-8)
Conjugate
Purified, with BSA
Documents
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
HCG-alpha (HCGa/53), CF594 conjugate, 0.1mg/mL
